company background image
IVAC

Intervacc OM:IVACC Stock Report

Last Price

kr36.32

Market Cap

kr1.8b

7D

-1.8%

1Y

-54.0%

Updated

17 Aug, 2022

Data

Company Financials +
IVACC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth6/6
Past Performance0/6
Financial Health5/6
Dividends0/6

IVACC Stock Overview

Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care.

Intervacc AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Intervacc
Historical stock prices
Current Share Pricekr36.32
52 Week Highkr81.00
52 Week Lowkr28.68
Beta1.42
1 Month Change-9.43%
3 Month Change-8.05%
1 Year Change-53.97%
3 Year Change182.65%
5 Year Change329.82%
Change since IPO371.69%

Recent News & Updates

Apr 28
We're Not Worried About Intervacc's (STO:IVACC) Cash Burn

We're Not Worried About Intervacc's (STO:IVACC) Cash Burn

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Shareholder Returns

IVACCSE BiotechsSE Market
7D-1.8%1.9%3.5%
1Y-54.0%-21.1%-20.7%

Return vs Industry: IVACC underperformed the Swedish Biotechs industry which returned -21.1% over the past year.

Return vs Market: IVACC underperformed the Swedish Market which returned -20.7% over the past year.

Price Volatility

Is IVACC's price volatile compared to industry and market?
IVACC volatility
IVACC Average Weekly Movement7.9%
Biotechs Industry Average Movement9.5%
Market Average Movement7.1%
10% most volatile stocks in SE Market12.5%
10% least volatile stocks in SE Market4.5%

Stable Share Price: IVACC is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: IVACC's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a13Andreas Anderssonhttps://www.intervacc.se

Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles.

Intervacc AB (publ) Fundamentals Summary

How do Intervacc's earnings and revenue compare to its market cap?
IVACC fundamental statistics
Market Capkr1.85b
Earnings (TTM)-kr33.62m
Revenue (TTM)kr8.91m

205.8x

P/S Ratio

-54.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IVACC income statement (TTM)
Revenuekr8.91m
Cost of Revenuekr2.49m
Gross Profitkr6.42m
Other Expenseskr40.05m
Earnings-kr33.62m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 31, 2022

Earnings per share (EPS)-0.67
Gross Margin72.08%
Net Profit Margin-377.28%
Debt/Equity Ratio0.07%

How did IVACC perform over the long term?

See historical performance and comparison